This inventor holds 2 USPTO granted patents. Top assignee: Tsumura Co., Ltd.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Hiroaki Kumazawa: Innovator in Pharmaceutical Chemistry
Introduction
Hiroaki Kumazawa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compositions. With a total of 2 patents to his name, Kumazawa's work focuses on addressing critical health conditions.
Latest Patents
Kumazawa's latest patents include "Cinnamamide derivatives and drug compositions containing the same" and "Compositions and methods for treating nephritis and inhibiting TGF-β related conditions using pyridylacrylamide derivatives." The latter patent describes an agent for treating nephritis and a TGF-β inhibiting agent that comprises a pyridylacrylamide derivative as an effective ingredient.
Career Highlights
Kumazawa is currently associated with Tsumura Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment of nephritis and related conditions.
Collaborations
Kumazawa collaborates with esteemed colleagues, including Tatsuhiro Obata and Shouichirou Shindou, to further enhance the scope and effectiveness of his research.
Conclusion
Hiroaki Kumazawa's innovative contributions to pharmaceutical chemistry exemplify the importance of research in developing effective treatments for serious health conditions. His patents reflect a commitment to improving patient outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile